Reconciliations to the most directly comparable GAAP financial measures can be found in today's earnings press release, which is available in the Investor Relations section of our website. Revenue from continuing operations was $14 million, down 4% year over year and up 8% sequentially. Growth was driven this quarter by our FTIR devices, which accounted for 42% of revenue, as we continue to see very strong demand for our Explorer Gas Identification device. Considering our year-to-date progress, revenues from continuing operations for the first nine months totaled $38.8 million, representing an increase of 16% year over year.

Growth in this channel and in our recurring revenues are key parts of our strategy to enhance predictability, as this is more run-rate business versus large enterprise device deals, which can be lumpy. We also made excellent progress towards our adjusted EBITDA target for 2025. Overall, I'm pleased with our execution this quarter as we continue to build momentum towards our growth and profitability goals. While our transform strategy is taking hold and our Q4 pipeline remains healthy, we continue to gauge the effects from the protracted U.S.

First, demand from state and local customers remains strong, supported by multi-year federal grant programs that remain active. Third, while smaller federal and defense orders have continued to move forward, larger awards have experienced delays due to constrained staffing and contracting authorities. We estimate that approximately $4 million of our Q4 revenue could be potentially impacted by delays in these areas. However, our base case remains that we are on track to achieve our full-year guidance, and we view any near-term impact as a timing issue as our strategic alignment remains strong.

What went well
  • Nine-month revenue from continuing operations reached $38.8 million, up 16% year over year, and third-quarter revenue of $14.0 million rose 8% sequentially.
  • Installed base grew 27% year over year to more than 3,500 devices (over 4,200 including approximately 700 legacy FTIR units placed before the RedWave acquisition).
  • Adjusted EBITDA loss narrowed to just $1.8 million - the company's lowest since its IPO - down 53% sequentially and 32% year over year, keeping the Q4 adjusted-EBITDA-positive goal in reach.
  • Record XplorIR quarter with placements up 30% sequentially; the U.S. Coast Guard purchased 23 MX908 devices and the U.S. Marine Corps CBRNE program purchased 17 XplorIR units.
  • Adjusted gross margin improved sequentially to 58%, an early benefit of the Danbury manufacturing consolidation.
  • Shipped the first VipIR unit to a Southeast Asian government intelligence agency (a competitor displacement) and secured more than 35 VipIR units for Q4 shipment.
  • U.S. state and local channel represented 47% of nine-month revenue, improving predictability versus lumpy federal enterprise deals; Team Leader software surpassed 700 users.
  • Ended the quarter with $112.1 million in cash and marketable securities and no debt.
What went wrong
  • Third-quarter revenue fell 4% year over year, driven by fewer multi-unit MX908 orders from U.S. federal and defense customers.
  • The protracted U.S. government shutdown put an estimated $4 million of Q4 revenue potentially at risk, with larger federal awards slowed by constrained contracting authorities and some international deliveries subject to export-license timing.
  • Gross margin was 53% (down from 54%) and adjusted gross margin declined about 60 basis points to 58%, on less favorable product mix and unabsorbed costs from the new in-house precision-machining operation.
  • The company consumed approximately $6.5 million of cash, including $2 million for the KAF asset acquisition.
  • Handheld revenue guidance was trimmed by $0.5 million to reflect a funding-related pause in service coverage by a U.S. defense customer (about a $500,000 quarterly headwind beginning in Q4).
  • AVCAD still contributed no meaningful 2025 revenue, with next-phase clarity pending completion of a final field-validation event.

Guidance Changes

MetricPeriodCurrent guidance
FY2025 revenue from continuing operationsFY2025maintained at $54-$56 million (13%-17% growth)
FY2025 handheld product & service revenueFY2025grow 16%-20% ($51.5-$53.5M); trimmed ~$0.5M on a defense service-coverage funding pause
FY2025 OEM & funded partnerships (incl. contract revenue)FY2025~$2.5 million (+$0.5M, incl. KAF contribution)
FY2025 adjusted gross marginFY2025mid-to-high 50% range (56% for the nine months)
Q4 adjusted EBITDAQ4 FY2025still targeting positive, assuming the government resumes normal contracting; ~$4M of Q4 revenue at risk from the shutdown

Performance Breakdown

MetricYoYNote
Total revenue (continuing ops) -4% to $14.0 million (+8% sequentially) Fewer large multi-unit MX908 federal/defense orders, offset by state and local momentum
Handheld product & service revenue -5% to $13.2 million Lower federal MX908 orders (176 devices shipped vs. 178)
OEM & funded partnership revenue +$0.3M to $0.8 million Pharma and industrial QA/QC customers plus KAF component sales
Recurring revenue +10% to $4.8 million (~35% of revenue) Consumables, accessories and service growth
Adjusted EBITDA loss of $1.8 million (-32% YoY, -53% sequentially) Aggressive cost initiatives across facilities, R&D and professional fees
Adjusted gross margin 58%, down ~60 bps Product mix and unabsorbed new-machining costs
Installed base +27% to 3,512 (>4,200 incl. legacy FTIR) 176 devices placed

Earnings Call Themes & Trends

TopicPrevious mentionCurrent periodTrend
908 Devices 2.0 transformationExecuting three focus areasBest adjusted EBITDA since IPO; portfolio expanded from one to five handheld products; customer concentration reduced
U.S. government shutdownNot a factor last quarter~$4M of Q4 revenue potentially delayed; state/local and international more insulated than large federal awards
VipIR rampLaunched in JulyFirst unit shipped to a Southeast Asian intelligence agency; >35 units secured for Q4; a rising 2026 contributor
Autonomous / unmanned platformsEarly interceptor use at eventsThales Group UGV collaboration; extending analytical platforms to ground robots and drones
Recurring revenue and state/local mixBuilding predictabilityState/local = 47% of nine-month revenue; Team Leader >700 users as a future recurring contributor

Q&A Summary

Is the $4 million of shutdown-exposed revenue included in the full-year guide, and what if it slips?
Griffith confirmed Q4 guidance includes run-rate business plus larger enterprise orders (~60 units, ~$3 million) and that guidance assumes the government normalizes so orders ship before year-end; the company builds to forecast and holds inventory.
How should we think about AVCAD in 2026 and the Coast Guard order?
Knopp said AVCAD completed a final field-validation event with next-step clarity expected by year-end; Griffith confirmed the Coast Guard's 23 MX908 units shipped in Q3 and that AVCAD is a growth catalyst that could contribute to 2026 product growth.
What are the sensitivities around hitting adjusted-EBITDA break-even given the shutdown?
Griffith said the main risk is not landing the ~$3 million of high-probability federal/defense orders plus ~$1 million of at-risk revenue; absent those, break-even timing could shift, but the underlying cost structure supports the target.
Update on the next-gen MX908 opportunity as the replacement cycle approaches?
Knopp reaffirmed innovation and new products as one of three growth catalysts, with XplorIR and the recently launched VipIR as proof points and the next-gen MX908 on track for 2026.
Where are you seeing the most interest in VipIR?
Knopp said VipIR shipped its first unit in Q3 with good feedback, remains a small Q4 contributor and a rising 2026 contributor, with strong customs and international interest.
Any production or supply-chain risk to full AVCAD fulfillment given the bigger portfolio?
Knopp said the Danbury consolidation is complete and up and running for Q3, including MX908 core components, positioning the company to scale without undue supply-chain risk.

More on 908 Devices Inc.

Reported 2025-11-10 · figures from the 908 Devices Inc. Q3 2025 earnings call.

See how VectorShift works for your firm

Request Demo